114
|
424
|
4iclB |
Hiv-1 reverse transcriptase with bound fragment at the incoming dntp binding site |
116
|
424
|
4ig0B |
Hiv-1 reverse transcriptase with bound fragment at the 507 site |
49
|
154
|
4id1A |
Hiv-1 integrase catalytic core domain complexed with allosteric inhibitor |
167
|
556
|
4ig3A |
Hiv-1 reverse transcriptase with bound fragment near knuckles site |
164
|
556
|
4id5A |
Hiv-1 reverse transcriptase with bound fragment at the rnase h primer grip site |
116
|
424
|
4ifyB |
Hiv-1 reverse transcriptase with bound fragment at the knuckles site |
122
|
424
|
4id5B |
Hiv-1 reverse transcriptase with bound fragment at the rnase h primer grip site |
20
|
99
|
4i8zA |
Crystal structure of wild type hiv-1 protease in complex with non-peptidic inhibitor, grl008 |
112
|
424
|
4i2qB |
Crystal structure of k103n/y181c mutant of hiv-1 reverse transcriptase in complex with rilpivirine (tmc278) analogue |
165
|
556
|
4ifyA |
Hiv-1 reverse transcriptase with bound fragment at the knuckles site |
114
|
424
|
4idkB |
Hiv-1 reverse transcriptase with bound fragment at the 428 site |
45
|
154
|
4jlhA |
Hiv-1 integrase catalytic core domain a128t mutant complexed with allosteric inhibitor |
161
|
556
|
4idkA |
Hiv-1 reverse transcriptase with bound fragment at the 428 site |
167
|
556
|
4ifvA |
Detecting allosteric sites of hiv-1 reverse transcriptase by x-ray crystallographic fragment screening |
16
|
99
|
4j5jA |
Crystal structure of multidrug resistant hiv-1 protease clinical isolate pr20 in complex with amprenavir |
19
|
99
|
4jecA |
Joint neutron and x-ray structure of per-deuterated hiv-1 protease in complex with clinical inhibitor amprenavir |
15
|
99
|
4hvpA |
Structure of complex of synthetic hiv-1 protease with a substrate-based inhibitor at 2.3 angstroms resolution |
102
|
428
|
4h4mB |
Crystal structure of hiv-1 reverse transcriptase in complex with (e)-3-(3-chloro-5-(4-chloro-2-(2-(2,4-dioxo-3,4- dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)phenyl)acrylonitrile (jlj494), a non-nucleoside inhibitor |
20
|
99
|
4he9A |
Crystal structure of hiv-1 protease mutants i54m complexed with inhibitor grl-0519 |
141
|
549
|
4h4oA |
Crystal structure of hiv-1 reverse transcriptase (rt) in complex with (e)-3-(3-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)- 4-fluorophenoxy)-5-fluorophenyl)acrylonitrile (jlj506), a non-nucleoside inhibitor |
20
|
99
|
4hegA |
Crystal structure of hiv-1 protease mutants r8q complexed with inhibitor grl-0519 |
103
|
428
|
4h4oB |
Crystal structure of hiv-1 reverse transcriptase (rt) in complex with (e)-3-(3-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)- 4-fluorophenoxy)-5-fluorophenyl)acrylonitrile (jlj506), a non-nucleoside inhibitor |
19
|
99
|
4hlaA |
Crystal structure of wild type hiv-1 protease in complex with darunavir |
19
|
99
|
4hdfA |
Crystal structure of hiv-1 protease mutants v82a complexed with inhibitor grl-0519 |
135
|
548
|
4h4mA |
Crystal structure of hiv-1 reverse transcriptase in complex with (e)-3-(3-chloro-5-(4-chloro-2-(2-(2,4-dioxo-3,4- dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)phenyl)acrylonitrile (jlj494), a non-nucleoside inhibitor |
19
|
99
|
4hdpA |
Crystal structure of hiv-1 protease mutants i50v complexed with inhibitor grl-0519 |
18
|
99
|
4hdbA |
Crystal structure of hiv-1 protease mutants d30n complexed with inhibitor grl-0519 |
49
|
155
|
4gw6A |
Hiv-1 integrase catalytic core domain complexed with allosteric inhibitor |
44
|
155
|
4gvmA |
Hiv-1 integrase catalytic core domain a128t mutant complexed with allosteric inhibitor |
16
|
99
|
4gb2A |
Hiv-1 protease (mutant q7k l33i l63i) in complex with a bicyclic pyrrolidine inhibitor |
157
|
556
|
4g1qA |
Crystal structure of hiv-1 reverse transcriptase (rt) in complex with rilpivirine (tmc278, edurant), a non-nucleoside rt-inhibiting drug |
117
|
424
|
4g1qB |
Crystal structure of hiv-1 reverse transcriptase (rt) in complex with rilpivirine (tmc278, edurant), a non-nucleoside rt-inhibiting drug |
18
|
99
|
4flgA |
Hiv-1 protease mutant i47v complexed with reaction intermediate |
20
|
99
|
4fe6A |
Crystal structure of hiv-1 protease in complex with an enamino-oxindole inhibitor |
18
|
99
|
4fl8A |
Hiv-1 protease complexed with gem-diol-amine tetrahedral intermediate |
19
|
99
|
3r4bA |
Crystal structure of wild-type hiv-1 protease in complex with tmc310911 |
19
|
99
|
4fm6A |
Hiv-1 protease mutant v32i complexed with reaction intermediate |
115
|
425
|
3qipB |
Structure of hiv-1 reverse transcriptase in complex with an rnase h inhibitor and nevirapine |
17
|
99
|
3qroA |
Hiv-1 protease (mutant q7k l33i l63i) in complex with a three-armed pyrrolidine-based inhibitor |
19
|
99
|
3qp0A |
Hiv-1 protease (mutant q7k l33i l63i) in complex with a novel inhibitor |
43
|
148
|
3qinA |
Crystal structure of hiv-1 rnase h p15 with engineered e. coli loop and pyrimidinol carboxylic acid inhibitor |
43
|
148
|
3qioA |
Crystal structure of hiv-1 rnase h with engineered e. coli loop and n-hydroxy quinazolinedione inhibitor |
18
|
99
|
3qrmA |
Hiv-1 protease (mutant q7k l33i l63i) in complex with a three-armed pyrrolidine-based inhibitor |
16
|
99
|
3qpjA |
Hiv-1 protease (mutant q7k l33i l63i) in complex with a three-armed pyrrolidine-based inhibitor |
19
|
99
|
3qihA |
Hiv-1 protease (mutant q7k l33i l63i) in complex with a novel inhibitor |
18
|
99
|
3qrsA |
Hiv-1 protease (mutant q7k l33i l63i) in complex with a three-armed pyrrolidine-based inhibitor |
18
|
99
|
3qn8A |
Hiv-1 protease (mutant q7k l33i l63i) in complex with a novel inhibitor |
139
|
553
|
3qo9A |
Crystal structure of hiv-1 reverse transcriptase (rt) in complex with tsao-t, a non-nucleoside rt inhibitor (nnrti) |
101
|
423
|
3qlhB |
Hiv-1 reverse transcriptase in complex with manicol at the rnase h active site and tmc278 (rilpivirine) at the nnrti binding pocket |
144
|
555
|
3qlhA |
Hiv-1 reverse transcriptase in complex with manicol at the rnase h active site and tmc278 (rilpivirine) at the nnrti binding pocket |